0001181431-14-021936.txt : 20140530
0001181431-14-021936.hdr.sgml : 20140530
20140530174140
ACCESSION NUMBER: 0001181431-14-021936
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140527
FILED AS OF DATE: 20140530
DATE AS OF CHANGE: 20140530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OMEGA PROTEIN CORP
CENTRAL INDEX KEY: 0001053650
STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070]
IRS NUMBER: 760438393
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2105 CITY WEST BLVD.
STREET 2: SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77042
BUSINESS PHONE: 713-623-0060
MAIL ADDRESS:
STREET 1: 2105 CITY WEST BLVD.
STREET 2: SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77042
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Toups Gregory P
CENTRAL INDEX KEY: 0001436243
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14003
FILM NUMBER: 14881528
MAIL ADDRESS:
STREET 1: OMEGA PROTEIN CORPORATION
STREET 2: 2105 CITY WEST BLVD., SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77042
4/A
1
rrd410639.xml
AMENDING FOOTNOTE 1 IN ORIGINAL FORM 4 FILED 5/29/2014
X0306
4/A
2014-05-27
2014-05-29
0
0001053650
OMEGA PROTEIN CORP
OME
0001436243
Toups Gregory P
2105 CITY WEST BOULEVARD
SUITE 500
HOUSTON
TX
77042
0
1
0
0
VP Ch Acct Officer & Controlle
Common Stock
2014-05-27
4
M
0
5000
7.54
A
35378
D
Common Stock
2014-05-27
4
S
0
5000
14.13
D
30378
D
Stock Option (right to buy)
7.54
2014-05-27
4
M
0
5000
0
D
2007-06-29
2016-12-27
Common Stock
5000
20000
D
This transaction is not new or revised but is being reported again for the sole purpose of gaining access to the EDGAR system.The purpose of filing this amendment to Form 4 dated May 29, 2014 for Gregory Toups ("Original Form 4") is to correct footnote 1 to the Original Form 4. That footnote stated that the 5,000 stock options exercised and the 5,000 shares of Common Stock sold reported in that Original Form 4 were exercised and sold pursuant to an SEC Rule 10b5-1 Trading Plan. Such stock options and shares were in fact not exercised and sold pursuant to a Rule 10b5-1 Trading Plan. All other items in the Original Form 4 remain unchanged and correct.
Value represents transactions with a weighted average sales price ranging from $14.07 to $14.30.
Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
Vests in 1/3 increments commencing on the first anniversary of date of grant.
Gregory P. Toups, by John D. Held, Attorney-in-Fact
2014-05-30